111951 ⎘
Bacteriophages; Details Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
NOVEL BACTERIOPHAGE COMPOSITIONS, FORMULATIONS AND METHODS OF MAKING AND USE
#2Novel Salmonella Enterica-Specific Bacteriophage OPT-SAL01, and Antibacterial Composition Comprising Same
#3SIMULTANEOUS PRODUCTION OF STRUCTURAL PROTEINS FROM HETEROLOGOUS BACTERIOPHAGE IN CELL-FREE EXPRESSION SYSTEM
#4PROPAGATOR CELLS AND METHODS FOR PROPAGATING PHAGE, IN PARTICULAR FOR DELIVERING CRISPR-CAS COMPONENTS VIA PROBIOTIC ORGANISMS
#5COMPOSITIONS AND METHODS FOR BACTERIOPHAGE INFECTION OF STAPHYLOCOCCUS BACTERIA
#6TARGETING CELLS IN STRESSED GROWING CONDITIONS
#7THERAPEUTIC COMPOSITIONS AND METHODS
#8ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#9ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#10ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#11Bacteriophages for Protection from Ultraviolet Irradiation
#12BACTERIOPHAGE HAVING BACTERIOLYSIS ACTIVITY ON XANTHOMONAS SPP.
#13BACTERIOPHAGES AND USE THEREOF FOR THE TREATMENT OR PREVENTION OF INFECTION CAUSED BY E. COLI
#14PRODUCTS OF MANUFACTURE AND METHODS TO ENRICH FOR AND ISOLATE VIRUSES OR PHAGES CAPABLE OF TARGETING SPECIFIC MICROBES
#15BACTERIOPHAGE PREPARATIONS AND METHODS OF USE
#16PHAGE THERAPY OF E COLI INFECTIONS
#17METHOD OF TREATING DRUG RESISTANT ESKAPEE PATHOGENS USING THERAPEUTIC BACTERIOPHAGES
#18IMMUNOGENIC COMPOSITION
#19BACTERIOPHAGES AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCI
#20DEVICE AND METHODS FOR ACNE THERAPEUTICS: ANTIBACTERIAL BACTERIOPHAGES AND ENGINEERED LYSINS
#21Bio-control methods for Xylella and Xanthomonas Bacteria
#22PSEUDOMONAS BACTERIOPHAGE AND USES THEREOF
#23NOVEL BACTERIOPHAGE HAVING ABILITY TO SPECIFICALLY KILL CLOSTRIDIUM PERFRINGENS AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME
#24BACTERIOPHAGES PRODUCING HETEROLOGOUS BACTERIOCINS
#25NOVEL BACTERIOPHAGE HAVING ENTEROTOXIGENIC ESCHERICHIA COLI-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME
#26FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE
#27PROPAGATOR CELLS AND METHODS FOR PROPAGATING PHAGE, IN PARTICULAR FOR DELIVERING CRISPR-CAS COMPONENTS VIA PROBIOTIC ORGANISMS
#28BACTERIOPHAGE TREATMENT FOR ACNE AND BIOFILMS
#29Bacteriophage composition and method of preventing bacterial infections in livestock
#30Altering microbial populations and modifying microbiota
#31MODIFIED BACTERIOPHAGE
#32Method for Reducing the Population of at Least One Intestinal and/or Gastrointestinal Bacteria Species Comprising Bacteriophages, and Bacteriophages and the Use Thereof
#33PHAGE DELIVERY OF ANTI-INFLAMMATORY PEPTIDES
#34PHAGE AND TRANSDUCTION PARTICLES
#35Treatment delivery system and method
#36THERAPEUTIC BACTERIOPHAGE COMPOSITIONS
#37MULTIPLE HOST RANGE BACTERIOPHAGE WITH HYBRID TAIL FIBRES
#38METHOD, COMPRISING BACTERIOPHAGES, FOR REDUCING THE POPULATION OF AT LEAST ONE ADIPOGENIC BACTERIAL SPECIES, AND BACTERIOPHAGES AND THE USE THEREOF
#39METHOD OF LONG-TERM PRESERVATION OF CHEMICAL AND BIOLOGICAL SPECIES USING SUGAR GLASSES
#40COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS
#41COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS
#42METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
#43Composition comprising amino acid polymers and a bioactive agent and method of preparing thereof
#44METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
#45METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
#46PHAGE COMPOSITIONS COMPRISING CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF
#47Genetically Engineered Bacteriophage
#48Altering microbial populations and modifying microbiota
#49Altering microbial populations and modifying microbiota
#50ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#51Methods of Identifying Bacteriophages that can Infect and Kill Host-Adapted Pathogenic Bacteria
#52Bacteriophage-Based Antibodies and Binders
#53Treatment of topical and systemic bacterial infections
#54Propagator cells and methods for propagating phage, in particular for delivering CRISPR-Cas components via probiotic organisms
#55Phage therapy
#56Products of manufacture and methods to enrich for and isolate viruses or phages capable of targeting specific microbes
#57Altering microbial populations and modifying microbiota
#58Fast diagnosis and personalized treatments for acne
#59THERAPEUTIC AND IMMUNOMODULATORY BACTERIOPHAGE FORMULATIONS AND METHODS FOR MAKING AND USING THEM
#60Phage therapy of infections
#61TREATMENT OF TOPICAL AND SYSTEMIC BACTERIAL INFECTIONS
#62Bacteriophage composition and method of preventing bacterial infections in livestock
#63Composition comprising amino acid polymers and a bioactive agent and method of preparing thereof
#64Altering microbial populations and modifying microbiota
#65Synthetic bacteriophages and bacteriophage compositions
#66Altering microbial populations and modifying microbiota
#67PHAGE AND TRANSDUCTION PARTICLES
#68ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#69Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles
#70Therapeutic bacteriophage compositions
#71ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#72ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#73Methods and Compositions for Treating Obesity, Inflammation, or Metabolic Disorders with Bacteriophages
#74ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#75ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#76THERAPEUTIC BACTERIOPHAGE COMPOSITIONS
#77TREATMENT OF TOPICAL AND SYSTEMIC BACTERIAL INFECTIONS
#78FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE
#79Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome
#80Bacteriophage compositions comprising respiratory antibacterial phages and methods of use thereof
#81Probiotic recolonisation therapy
#82Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
#83DNA NANOROBOT AND METHODS OF USE THEREOF
#84ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#85DNA, METHODS ETC
#86Bacteriophage and composition comprising same
#87Altering microbial populations and modifying microbiota
#88Anti-bacterial compositions comparing lytic modified bacteriophage engineered to infect and kill different target bacteria
#89Methods and compositions for preventing infection by a species
#90Modifying bacteriophage
#91Immunogenic composition
#92Modified bacteriophage
#93Methods of identifying bacteriophages that can infect and kill host-adapted infectious pathogenic bacteria
#94Bacteriophage strains against proteus mirabilis and use thereof
#95DEVICES, SYSTEMS AND METHODS FOR THE PRODUCTION OF HUMANIZED GUT COMMENSAL MICROBIOTA
#96Probiotic recolonisation therapy
#97Bacteriophage compositions and methods of use thereof
#98Bacteriophage and antibacterial composition comprising the same
#99Devices, systems and methods for the production of humanized gut commensal microbiota
#100PREBIOTIC COMPOSITIONS COMPRISING ONE OR MORE TYPES OF BACTERIOPHAGE
#101Synthetic bacteriophages and bacteriophage compositions
#102ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#103Treatment of bacterial infections in aquaculture
#104DEVICES, SYSTEMS AND METHODS FOR THE PRODUCTION OF HUMANIZED COMMENSAL MICROBIOTA
#105Altering microbial populations and modifying microbiota
#106Altering microbial populations and modifying microbiota
#107Altering microbial populations and modifying microbiota
#108Altering microbial populations and modifying microbiota
#109Altering microbial populations and modifying microbiota
#110BACTERIOPHAGE-CONTAINING THERAPEUTIC AGENTS
#111Devices, systems and methods for the production of humanized gut commensal microbiota
#112Devices, systems and methods for the production of humanized gut commensal microbiota
#113Devices, systems and methods for the production of humanized gut commensal microbiota
#114DEVICES, SYSTEMS AND METHODS FOR THE PRODUCTION OF HUMANIZED GUT COMMENSAL MICROBIOTA
#115Bacteriophage compositions and methods of selection of components against specific bacteria
#116Genetically Modified Bacteriophage (Bio-Phage)
#117Phage therapy
#118Multiple host range bacteriophage with hybrid tail fibres
#119Multiple host range bacteriophage with different tail fibres
#120MODIFYING BACTERIOPHAGE USING BETA-GALACTOSIDASE AS A SELECTABLE MARKER
#121Altering microbial populations and modifying microbiota
#122BENEFICIAL EFFECTS OF BACTERIOPHAGE TREATMENTS
#123Pegylated recombinant bacteriophage
#124Altering microbial populations and modifying microbiota
#125PHAGE TO TREAT BACTERIA ON SKIN
#126Therapeutic bacteriophage compositions
#127Fast diagnosis and personalized treatments for acne
#128Bacteriophage and composition comprising same
#129Method of inhibiting the growth of
#130Phage therapy of infections
#131Composition comprising a polymer and a bioactive agent and method of preparing thereof
#132Probiotic recolonisation therapy
#133Probiotic recolonisation therapy
#134Probiotic recolonisation therapy
#135Compositions for in vivo expression of therapeutic sequences in the microbiome
#136Modified bacteriophage
#137Antibacterial phage, phage peptides and methods of use thereof
#138Probiotic recolonisation therapy
#139Probiotic recolonisation therapy
#140PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME
#141bacteriophages and uses thereof
#142Probiotic recolonisation therapy
#143Probiotic recolonisation therapy
#144Probiotic recolonisation therapy
#145Probiotic recolonisation therapy
#146Bacteriophage and antibacterial composition comprising the same
#147bacteriophage and uses thereof
#148Method for prevention and treatment of infection
#149METHODS AND COMPOSITIONS FOR BACTERIOPHAGE THERAPY
#150Antibacterial phage, phage peptides and methods of use thereof
#151Compositions and Methods for Targeted Gene Disruption in Prokaryotes
#152Method for prevention and treatment of infections using a bacteriophage with broad antibacterial spectrum against
#153Probiotic recolonisation therapy
#154Probiotic recolonisation therapy
#155Probiotic recolonisation therapy
#156Prebiotic compositions comprising one or more types of bacteriophage
#157Therapeutic bacteriophages
#158Probiotic recolonisation therapy
#159Targeted and modular exosome loading system
#160Fast Diagnosis and Personalized Treatment for Acne
#161Bacteriophage preparations and methods of use thereof
#162bacteriophage P825 and uses thereof
#163Bacteriophage having bactericidal activity with respect to
#164Isolated bacteriophage having -specific bactericidal activity and antibacterial composition comprising the same
#165Polypeptides and bacteriophages specific to capsular type strains
#166Bacteriophage with activity against pathogenic strains of
#167Delivery of viral agents
#168Antibacterial phage, phage peptides and methods of use thereof
#169Salmonella bacteriophage and uses thereof
#170Bacteriophage-containing therapeutic agents
#171Method for Prevention and Treatment of Salmonella Infection
#172DEFINED DOSE THERAPEUTIC PHAGE
#173ENCAPSULATED BACTERIOPHAGE FORMULATION
#174Methods for Generation of Reporter Phages and Immobilization of Active Bacteriophages on a Polymer Surface
#175METHOD FOR USING LIBERATED DORMANT BACTERIOPHASE AND ENVIRONMENTAL STRESS TO REDUCE INFECTIOUS BACTERIA
#176Reduction In Bacterial Colonization By Administering Bacteriophage Compositions
#177Bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus
#178Bacteriophage-containing therapeutic agents
#179DEFINED DOSE THERAPEUTIC PHAGE
#180Compositions for preventing and treating uterine disease
#181Antibacterial phage, phage peptides and methods of use thereof
#182COMPOSITIONS AND METHODS OF USE OF TARGETING PEPTIDES FOR DIAGNOSIS AND THERAPY OF HUMAN CANCER
#183Methods for Bacteriophage Design
#184Bacteriophage compositions for treatment of bacterial infections
#185Bacteriophage-containing therapeutic agents
#186Bacteriophage preparations and methods of use thereof
#187BACTERIOPHAGE PREPARATION AND USE
#188Bacteriophage or lytic protein derived from the bacteriophage which effective for the treatment of biofilm
#189Modified bacteriophage including an alpha/beta small acid-soluble spore protein (SASP) gene
#190Bacteriophage and their uses
#191Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
#192Beneficial effects of bacteriophage treatments
#193Bacteriophage preparations and method of use thereof
#194Methods for generation of reporter phages and immobilization of active bacteriophages on a polymer surface
#195Composition for the treatment of ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water
#196METHOD FOR USING LIBERATED DORMANT BACTERIOPHAGE AND ENVIRONMENTAL STRESS TO REDUCE INFECTIOUS BACTERIA
#197Reduction in bacterial colonization by administering bacteriophage compositions
#198Bacteriophage and their uses
#199Encapsulated Bacteriophage Formulation
#200Bacterial Management in Animal Holding Systems
#201Method of treating gastrointestinal diseases associated with species of genus
#202Bacteriophages as selective agents for enriching target bacteria
#203Methods for isolating phage and for controlling microorganism populations with the phage
#204Stabilized bacteriophage formulations
#205GRP78 targeting peptides and methods employing same
#206USE OF VIRUSES AND VIRUS-RESISTANT MICROORGANISMS FOR CONTROLLING MICROORGANISM POPULATIONS
#207Bacteriophage-containing therapeutic agents
#208Defined dose therapeutic phage
#209Bacteriophage and their uses
#210Production of bacteriophage compositions for use in phage therapy
#211Use of viruses and virus-resistant microorganisms for controlling microorganism populations
#212Bacteriophage for the treatment of bacterial biofilms
#213Bacteriophages as selective agents
#214Compositions containing bacteriophages and method of using bacteriophages to treat infections
#215Compositions and methods of use of targeting peptides for diagnosis and therapy
#216Method for produce sanitation using bacteriophages
#217Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections
#218Particle delivery via small-scale morphology materials for antibacterial applications